Meta-Analysis of Biochemical and Patient-Level Effects of Calcimimetic Therapy
Authors:
- Giovanni F.M. StrippoliGSGiovanni F.M. Strippoli
- Suetonia PalmerSPSuetonia Palmer
- Allison TongATAllison Tong
- Grahame ElderGEGrahame Elder
- Piergiorgio MessaPMPiergiorgio Messa
- Jonathan C. CraigJCJonathan C. Craig
- 1 May 2006
- journal article
- review article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 47 (5) , 715-726
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Steroid Sparing with Tacrolimus and Mycophenolate Mofetil in Renal TransplantationAmerican Journal of Transplantation, 2004
- Mineral Metabolism, Mortality, and Morbidity in Maintenance HemodialysisJournal of the American Society of Nephrology, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- Higher impact of mineral metabolism on cardiovascular mortality in a European hemodialysis populationKidney International, 2003
- Hyperphosphataemia in Renal FailureDrugs, 2003
- Bone biopsy results and serum bone turnover parameters in uremic childrenActa Paediatrica, 2000
- Calcimimetics in actionKidney International, 1998
- Enrollment parathyroid hormone level is a new marker of survival in hemodialysis and peritoneal dialysis therapy for uremiaAmerican Journal of Kidney Diseases, 1996
- Relationship between intact 1–84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicityAmerican Journal of Kidney Diseases, 1995
- Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysisAmerican Journal of Kidney Diseases, 1995